Public encouraged to vote for winner
PARSIPPANY, N.J., Oct. 7, 2013 /PRNewswire-USNewswire/ -- Today, Ferring Pharmaceuticals announced the top five finalists in its 2013 Heart to Heart Video Contest. The contest gives parents who have struggled with infertility a chance to win up to $15,000 toward their child's education by sharing their story of becoming a parent. Now through October 21, 2013, it's the public's turn to help select a winner by visiting www.hearttoheartcontest.com to cast their vote for their favorite video.
The 2013 Heart to Heart Video Contest finalists include:
-- Diane Ciccone from Townsend, Delaware; -- Iane Costa from San Diego, California; -- Aren Dodge from Warrenton, Virginia; -- Gena Marino from Alexandria, Virginia; -- Erica Rosen from Mountain View, California.
To learn more about their stories, visit www.hearttoheartcontest.com.
"We are excited to showcase these stories of hope for other families who may also be struggling with infertility," said Nick Hart, Ferring's Business Unit Head for U.S. Reproductive Health. "All of the finalists' submissions were outstanding and captured their steps to parenthood in creative and engaging ways. We look forward to naming a winner with the help of the community."
The finalist who receives the most votes for their video by October 21, 2013 will win $15,000, while the remaining finalists will each win $2,000 toward their child's education.
Launched in March, the 2013 Heart to Heart Contest encouraged parents who have struggled with infertility to submit a creative video that showed the steps they took to achieve their dream of parenthood.
To learn more about the Heart to Heart Video Contest, visit www.hearttoheartcontest.com.
About Ferring Pharmaceuticals
Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of reproductive health, urology, gastroenterology, endocrinology and osteoarthritis. For more information, visit www.ferringUSA.com.
SOURCE Ferring Pharmaceuticals Inc.